CHE | Chemed CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$542.18
+$7.46 (+1.40%)

Chemed Corporation (CHE) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $542.18 vs 50 $514.77 / 200 $463.18
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 Jul 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $534.72 vs 50 $458.74 / 200 $522.55
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 6 Oct 2025 ยท projected 22 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $533.65 vs 50 $514.43 / 200 $507.12
Projection
No cross projected
Test
No active test
Last cross
Golden cross 26 May 2026 bar 1 ยท projected 26 bars out ยท tested 1 bar

Cross history

31
crosses on record since 2018
15 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Jul 2026Golden steepdaily21 bars outNot tested
26 May 2026Golden4-hour26 bars out1 bar cross test
13 Mar 2026Death4-hour16 bars outNot tested
27 Jan 2026Golden4-hour23 bars out4 bar cross test
week of 6 Oct 2025Death moderateweekly22 bars outNot tested

About CHE

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$70.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.